Dyadic Yoga Program for Patients Undergoing Thoracic Radiotherapy and Their Family Caregivers: The Testing of a Mobile Application Delivery
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
- Procedures mentioned: Interviews
Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.
Show the study's own words
- "The Investigators will also complete semi-structured interviews to collect qualitative data on participants' evaluation of the mobile app and their experience in participating in this research."
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study tests a yoga program done through an app without supervision. It looks at how easy the program is to use, whether people can take part, and how well they like it. It is for people getting radiation to the chest for certain cancers and their family caregivers.
The goal of the trial is to test the usability, feasibility and acceptability of an unsupervised, appbased yoga program for participants undergoing thoracic RT and their caregivers.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Patients must have non-small cell lung cancer or esophageal cancer (cancer of the tube that carries food to the stomach).
- Patients must be scheduled for at least 24 radiation treatments to the chest.
- Patients must have an ECOG activity score below 2, meaning they can do most daily activities.
- Patients must have a family caregiver, such as a spouse, sibling, or adult child, willing to join.
- Both the patient and caregiver must be older than 18.
- Both must be able to read and speak English.
- Both must be able to understand the study and agree to join.
- Both must have regular access to Wi-Fi or high-speed internet.
Who can't join
- Thinking or memory problems that the cancer doctor believes would prevent completing questionnaires, or confusion about time, place, or who they are.
- Regular participation in a yoga program during the year before diagnosis.
- People who joined part 1 of this study cannot join part 2.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: 1. Be diagnosed with a non-small cell lung cancer or esophageal cancer and going to receive at least 24 fractions thoracic RT 2. Have an ECOG performance status of \<2 3. Have a family caregiver (e.g., spouse, sibling, adult child) willing to participate Both patient and caregiver must meet all the following criteria: 1. Be \>18 years old 2. Be able to read and speak English 3. Be able to provide informed consent 4. Have regular (self-defined) access to Wi-Fi/High speed internet access Exclusion Criteria: 1. Experiences cognitive deficits that would impede the completion of self-report instruments as deemed by their attending oncologist per medical notes and/or patient not being oriented to time, place and person. 2. Regularly (self-defined) participants in a yoga program in the year prior to diagnosis Participants who participated in part 1 are ineligible to participate in part 2 of this protocol.
Study sites (1)
TX
- The University of Texas M. D. Anderson Cancer Center · Houston, TX 77030Kathrin Milbury, MA,PHD · Study contact · 713-745-2868 · kmilbury@mdanderson.orgKathrin Milburey, MA,PHD · Principal investigatorMore trials in Houston